CN Patent

CN104860935A — 作为丙肝病毒抑制剂的噻吩或其变体衍生物及其制药用途

Assigned to CHANGZHOU YINSHENG PHARMACEUTICAL CO LTD · Expires 2015-08-26 · 11y expired

What this patent protects

本发明公开了一系列作为丙型肝炎病毒（HCV）抑制剂的噻吩或其变体衍生物及其组合物，并涉及其在制备治疗慢性丙型肝炎病毒感染药物中的应用。具体地，本发明涉及作为NS5A抑制剂的系列化合物及其组合物和制药用途。

USPTO Abstract

本发明公开了一系列作为丙型肝炎病毒（HCV）抑制剂的噻吩或其变体衍生物及其组合物，并涉及其在制备治疗慢性丙型肝炎病毒感染药物中的应用。具体地，本发明涉及作为NS5A抑制剂的系列化合物及其组合物和制药用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN104860935A
Jurisdiction: CN
Classification: —
Expires: 2015-08-26
Drug substance claim: No
Drug product claim: No
Assignee: CHANGZHOU YINSHENG PHARMACEUTICAL CO LTD
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.